15篇高分综述：细胞焦亡，一个既老又新的科研热点

科研喵本人晚上读了好多细胞焦亡的综述，都是最新几个月见刊的，大神们写的综述，供大家一睹为快，方便大家下载，文末有下载方式，共15篇综述的原文。

1.The NLRP3 inflammasome: molecular activation and regulation to therapeutics.

Swanson KV, Deng M, Ting JP.

Nat Rev Immunol41.9821区. 2019 Apr 29. doi: 10.1038/s41577-019-0165-0. [Epub ahead of print] Review.

2.NLRP3 inflammasome couples purinergic signaling with activation of the complement cascade for the optimal release of cells from bone marrow.

Ratajczak MZ, Adamiak M, Thapa A, Bujko K, Brzezniakiewicz-Janus K, Lenkiewicz AM.

Leukemia10.0231区. 2019 Apr;33(4):815-825. doi: 10.1038/s41375-019-0436-6. Epub 2019 Mar 7. Review.

3.Diverging inflammasome signals in tumorigenesis and potential targeting.

Karki R, Kanneganti TD.

Nat Rev Cancer42.7841区. 2019 Apr;19(4):197-214. doi: 10.1038/s41568-019-0123-y. Review.

4.NLRP3 Inflammasome and Inflammatory Bowel Disease.

Zhen Y, Zhang H.

Front Immunol5.5112区. 2019 Feb 28;10:276. doi: 10.3389/fimmu.2019.00276. eCollection 2019. Review.

5.Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.

Yang Y, Wang H, Kouadir M, Song H, Shi F.

Cell Death Dis5.6382区. 2019 Feb 12;10(2):128. doi: 10.1038/s41419-019-1413-8. Review.

6.Targeting TLRs and the inflammasome in systemic sclerosis.

Henderson J, Bhattacharyya S, Varga J, O'Reilly S.

Pharmacol Ther10.3761区1. 2018 Dec;192:163-169. doi: 10.1016/j.pharmthera.2018.08.003. Epub 2018 Aug 4. Review.

7.Inflammasome signalling in brain function and neurodegenerative disease.

Heneka MT, McManus RM, Latz E.

Nat Rev Neurosci32.6351区7. 2018 Oct;19(10):610-621. doi: 10.1038/s41583-018-0055-7. Review. Erratum in: Nat Rev Neurosci. 2019 Mar;20(3):187.

8.Control of Inflammasome Activation by Phosphorylation.

Gong T, Jiang W, Zhou R.

Trends Biochem Sci15.6781区. 2018 Sep;43(9):685-699. doi: 10.1016/j.tibs.2018.06.008. Epub 2018 Jul 23. Review.

9.GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.

Tang T, Gong T, Jiang W, Zhou R.

Trends Pharmacol Sci12.1081区. 2018 Sep;39(9):798-811. doi: 10.1016/j.tips.2018.07.002. Epub 2018 Jul 24. Review.

10.Targeting the NLRP3 inflammasome in inflammatory diseases.

Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E.

Nat Rev Drug Discov50.1671区16. 2018 Aug;17(8):588-606. doi: 10.1038/nrd.2018.97. Epub 2018 Jul 20. Review. Erratum in: Nat Rev Drug Discov. 2018 Sep;17(9):688.

11.Inflammasome biology, molecular pathology and therapeutic implications.

Awad F, Assrawi E, Louvrier C, Jumeau C, Georgin-Lavialle S, Grateau G, Amselem S, Giurgea I, Karabina SA.

Pharmacol Ther10.3761区8. 2018 Jul;187:133-149. doi: 10.1016/j.pharmthera.2018.02.011. Epub 2018 Feb 18. Review.

12.NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

Grebe A, Hoss F, Latz E.

Circ Res15.2111区7. 2018 Jun 8;122(12):1722-1740. doi: 10.1161/CIRCRESAHA.118.311362. Review.

13.Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.

Gong T, Yang Y, Jin T, Jiang W, Zhou R.

Trends Immunol14.1881区8. 2018 May;39(5):393-406. doi: 10.1016/j.it.2018.01.009. Epub 2018 Feb 13. Review.

14.The NLRP3 inflammasome in acute myocardial infarction.

Toldo S, Abbate A.

Nat Rev Cardiol15.1621区13. 2018 Apr;15(4):203-214. doi: 10.1038/nrcardio.2017.161. Epub 2017 Nov 16. Review.

15.Inflammasome, Inflammation, and Tissue Homeostasis.

Rathinam VAK, Chan FK.

Trends Mol Med11.0211区5. 2018 Mar;24(3):304-318. doi: 10.1016/j.molmed.2018.01.004. Epub 2018 Feb 9. Review.